Helix TCS Expands into Global Markets
March 15th, 2019
News, Top Story
Many cannabis investors have focused their attention on North American markets, but emerging international markets could be the next frontier. Canadian licensed producers have started expanding into new export markets, consulting companies are offering their expertise, and ancillary service providers are expanding their products and services. Investors may want to take a closer look at companies that have embraced these kinds of expansion.
Helix TCS Inc. (OTCQB: HLIX) is a leading provider of ancillary services to the legal cannabis industry with over 2,000 customer locations in 33 US states and six countries around the world. With a proprietary technology suite and security service offerings, the company has processed over $18 billion in cannabis sales and helped countless businesses remain compliant with evolving government regulations.
In this article, we will take a look at some of the company’s international expansion efforts and why investors may want to take note.
Europe’s Nascent Cannabis Market
Europe has about 750 million citizens spread across 50 different countries, making it one of the largest potential cannabis markets in the world. By comparison, North America has roughly 580 million citizens spread across just 20 countries. Europe’s cannabis industry may not be as permissive as North America, but the European Parliament recently voted on a resolution that incentivizes European countries to increase access to medical cannabis.
Helix TCS recently announced an expansion into Europe via new agreements with licensed cultivators and manufacturers in the United Kingdom. These companies have started using the company’s flagship seed-to-sale tracking solution, BioTrackTHC, to track cannabis plants throughout the supply chain. The presence in the United Kingdom could be a springboard to the rest of Europe, including Germany’s rapidly growing market.
“As international markets develop and more countries create a legal cannabis industry, our technology and services solution will continue to reach new markets quickly to meet the needs of businesses and regulators in any regulatory environment,” says Helix TCS CEO Zachary L. Venegas. “We are very excited to see the progress of legal cannabis on the global stage and look forward to continuing to play a vital role.”
A Growing Presence in Australia
Australia’s cannabis industry could be worth upwards of $5.5 billion by 2023, according to Prohibition Partners, when factoring in both medical and recreational markets. In addition to already being a leading exporter of agricultural products, the country is well positioned to serve the lucrative Oceania region, which includes some of the most populous countries in the world—China, Japan, Singapore and Indonesia.
Helix TCS has already established a leadership position in the Australian and New Zealand cannabis markets. Demand for medical cannabis in both of these countries continues to rise as they lay the groundwork for safe and transparent patient access, which makes reliable and secure seed-to-sale tracking software essential to the industry’s success. BioTrackTHC’s proven track record makes it a natural choice for these seed-to-sale tracking capabilities.
“BioTrackTHC can service businesses in countries halfway around the world because of our geographically distributed team,” says BioTrackTHC Chief Operating Officer Dr. Moe Afaneh. “With support spanning more than four time zones, we are confident in our ability to support the medical cannabis operators in Australia and New Zealand as they prepare to launch and scale their businesses.”
Helix TCS Inc. (OTCQB: HLIX) is an established provider of ancillary cannabis products and services with an existing presence in 33 US states and six countries around the world. As new international markets open up, the company is well positioned to leverage its success in the most dominant global cannabis industries, ultimately creating significant barriers to competition.
The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/
Follow Us on Social Media
About CFN Media
CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.
CFN launched in June of 2013 to initially serve the growing universe of publicly traded marijuana companies across North America. Today, CFN Media is also the digital media choice for the emerging brands in the space.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.